Veterinary Diagnostics Market to Expand at 10.75% CAGR by 2035 | Discover Strategic Opportunities with Vantage Market Research

NEW YORK, Jan. 21, 2026 /PRNewswire/ -- The Global Veterinary Diagnostics Market is undergoing a strong transformation as veterinary healthcare systems worldwide increasingly prioritize early disease detection, preventive care, and precision diagnostics for companion and production animals. Rising pet ownership, growing awareness of animal health, increasing prevalence of zoonotic and chronic diseases, and expanding livestock productivity demands are accelerating adoption of advanced veterinary diagnostic technologies across clinics, laboratories, and research institutions.

Valued at USD 7.97 Billion in 2024, the Global Veterinary Diagnostics Market is projected to reach USD 24.44 Billion by 2035, expanding at a healthy CAGR of 10.75% during the forecast period (2025–2035). Market growth is supported by advancements in molecular diagnostics, rapid point-of-care testing, increasing investments in veterinary healthcare infrastructure, and the growing role of diagnostics in disease prevention and herd health management.

Veterinary diagnostics encompass a wide range of technologies and services used to detect, monitor, and manage diseases in animals, including immunoassays, molecular diagnostics, hematology, clinical chemistry, imaging, and rapid diagnostic tests. These solutions play a critical role in improving treatment outcomes, reducing disease transmission, and supporting evidence-based veterinary decision-making.

The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ https://www.vantagemarketresearch.com/veterinary-diagnostics-market-1529/request-sample

Free Sample Includes:

• Global & regional market size forecasts through 2035.
• Competitive benchmarking and SWOT analysis of top providers.
• Segmentation insights.
• Regulatory and sustainability landscape mapping.
• Porter's Five Forces and value chain assessment.
• Regional investment and technology adoption opportunities.

Veterinary Diagnostics Market Gains Momentum with Shift Toward Preventive & Precision Animal Care

Key factors driving market expansion include:

• Rising global pet adoption and increasing spending on companion animal healthcare
• Growing prevalence of infectious, chronic, and zoonotic diseases
• Increasing focus on preventive veterinary care and early diagnosis
• Expansion of livestock farming and demand for herd health monitoring
• Technological advancements in molecular and point-of-care diagnostics
• Growing awareness of animal welfare and food safety
• Rising investments in veterinary clinics, laboratories, and diagnostic infrastructure

Why Veterinary Diagnostics Is Becoming Mission-Critical for Veterinarians & Animal Health Stakeholders

• Need for early and accurate disease detection to improve treatment outcomes
• Rising demand for preventive care and routine health screening
• Increasing risk of zoonotic disease transmission
• Growing pressure to improve livestock productivity and food safety
• Demand for rapid, reliable, and cost-effective diagnostic solutions
• Integration of diagnostics into precision veterinary medicine

Technology Innovation Accelerating the Evolution of Veterinary Diagnostics

• Molecular diagnostics including PCR and next-generation sequencing
• Rapid and point-of-care diagnostic tests
• Immunoassays and advanced clinical chemistry platforms
• Digital imaging and diagnostic imaging solutions
• AI-enabled diagnostic interpretation and workflow automation
• Cloud-based laboratory information systems
• Integration with veterinary practice management software

Strategic Opportunities for Veterinary Diagnostics Companies & Investors

• Development of rapid and portable point-of-care diagnostic devices
• Expansion of molecular diagnostics for infectious and genetic diseases
• Growth opportunities in emerging markets with expanding veterinary infrastructure
• Partnerships with veterinary clinics, reference laboratories, and research institutions
• Integration of diagnostics with digital health and tele-veterinary platforms
• Focus on preventive diagnostics and wellness screening programs

Expert Perspectives

"Veterinary diagnostics is a cornerstone of modern animal healthcare. Advances in diagnostic accuracy and speed are enabling veterinarians to deliver better outcomes while supporting disease prevention and biosecurity," Nneha Rathod Godbole, CEO, Vantage Market Research

Email Directly Here with Detailed Information: sales@vantagemarketresearch.com

Market Landscape

The veterinary diagnostics market is characterized by continuous technological innovation, growing consolidation among diagnostic providers, and expanding adoption across companion animal and livestock applications. North America currently dominates the market due to high pet ownership, advanced veterinary infrastructure, and strong diagnostic adoption, while Asia Pacific is expected to witness the fastest growth, driven by expanding livestock populations, rising disposable incomes, and increasing investments in veterinary healthcare.

Market Momentum: Why Demand Is Strengthening

The global veterinary diagnostics market is gaining strong momentum as veterinarians and animal health stakeholders increasingly recognize the value of early diagnosis and preventive care. Growing pet humanization, heightened focus on animal welfare, and rising concerns around zoonotic diseases are reinforcing the critical role of diagnostics in modern veterinary medicine.

Key Growth Levers – Veterinary Diagnostics Market

• Expand preventive and herd health management through advanced diagnostics: Veterinary clinics, livestock producers, and animal health organizations are increasingly adopting diagnostic solutions to enable early disease detection, routine screening, and preventive care. Diagnostics support herd health monitoring, outbreak prevention, and improved treatment outcomes across companion and production animals.
• Invest in molecular diagnostics and rapid point-of-care testing: Adoption of PCR-based tests, immunoassays, and rapid diagnostic kits is strengthening veterinary diagnostic capabilities by enabling faster, more accurate detection of infectious, genetic, and chronic diseases. These technologies support timely clinical decisions, reduce disease spread, and improve survival rates.
• Integrate diagnostics with digital veterinary health ecosystems: Seamless integration of diagnostic platforms with veterinary practice management systems, laboratory information systems, tele-veterinary services, and digital record-keeping tools is streamlining workflows. This interoperability enables real-time result sharing, improved clinical collaboration, and data-driven veterinary decision-making.
• Strengthen diagnostics for zoonotic and infectious disease surveillance: Growing concerns around zoonotic diseases and food safety are accelerating demand for advanced diagnostic solutions in livestock and poultry. Veterinary diagnostics play a critical role in biosecurity, regulatory compliance, and disease surveillance programs at regional and national levels.
• Develop scalable and automated diagnostic solutions: Diagnostic manufacturers are focusing on high-throughput, automated, and scalable platforms suitable for reference laboratories, large veterinary hospitals, and commercial livestock operations. Emphasis on efficiency, accuracy, and cost optimization supports large-scale diagnostic testing.
• Enhance data accuracy, quality control, and regulatory compliance: Compliance with veterinary regulatory standards, quality assurance protocols, and laboratory accreditation requirements remains essential. Continuous investment in diagnostic validation, quality control systems, and data integrity strengthens trust and long-term market adoption.
• Expand access to veterinary diagnostics in emerging markets: Growth in emerging economies is supported by rising livestock populations, increasing pet ownership, expanding veterinary infrastructure, and government-led animal health initiatives. Affordable diagnostic kits, portable devices, and mobile testing solutions are improving access in underserved regions.
• Prioritize veterinary workforce training and diagnostic awareness: Effective utilization of advanced diagnostics depends on skilled veterinarians and technicians. Training programs, digital learning tools, and clinical decision support systems are essential to improve diagnostic adoption, interpretation accuracy, and overall care quality.

Buy this Premium Research Report | Immediate Delivery @ https://www.vantagemarketresearch.com/veterinary-diagnostics-market-1529/checkout

Benefits of Purchasing Veterinary Diagnostics Market Reports

• Analyst Support – Direct access to our experts before and after purchase for tailored insights and clarifications.
• Data Accuracy – Forecasts and trends validated through a combination of primary industry interviews, end-user surveys, and advanced statistical modeling.
• Decision-Making Tools – Interactive dashboards, granular segment forecasts, competitor benchmarking, and adoption roadmaps to guide strategy.
• Quality & Credibility – Trusted by Fortune 500 companies, healthcare innovators, and technology leaders for reliable market intelligence.

Recent Industry Developments

• Jan 2025: Launch of advanced molecular and rapid diagnostic platforms for companion and livestock animals
• Mar 2025: Expansion of point-of-care diagnostic solutions for infectious and chronic veterinary diseases
• Jun 2025: Strategic partnerships between veterinary diagnostic companies and animal health providers
• Aug 2025: Increased adoption of automated diagnostic systems in veterinary reference laboratories
• Oct 2025: Regulatory initiatives strengthening animal disease surveillance and food safety standards

Regional Market Overview

• North America: Market leadership driven by high pet ownership, advanced veterinary infrastructure, strong diagnostic adoption, and stringent animal health regulations
• Europe: Growth supported by preventive animal healthcare policies, food safety regulations, and increasing use of advanced diagnostics
• Asia Pacific: Fastest-growing region due to expanding livestock populations, rising pet humanization, improving veterinary services, and government animal health programs
• Latin America: Steady growth fueled by livestock industry expansion, disease control initiatives, and improving veterinary diagnostic access
• Middle East & Africa: Emerging opportunities supported by livestock health programs, veterinary infrastructure development, and growing awareness of animal disease prevention

Request a Customized Copy of the Veterinary Diagnostics Market Report@ https://www.vantagemarketresearch.com/veterinary-diagnostics-market-1529/request-customization

Segment Insights

By Product

• Consumables: The consumables segment accounts for a significant share of the veterinary diagnostics market due to the recurring nature of test usage. Reagents, kits, cartridges, and test strips are routinely consumed across diagnostic procedures, ensuring steady demand from veterinary hospitals, clinics, and reference laboratories. Growing testing volumes, increasing pet healthcare spending, and rising livestock disease surveillance are supporting sustained growth in this segment.
• Instruments: Diagnostic instruments play a critical role in delivering accurate and rapid results across veterinary settings. Increasing adoption of automated analyzers, point-of-care diagnostic devices, and advanced laboratory instruments is driving market growth. Demand is particularly strong for compact, user-friendly instruments that enable in-house testing and faster clinical decision-making.

By Technology

• Immunodiagnostics: Immunodiagnostics represents one of the most widely adopted technologies in veterinary diagnostics due to its high sensitivity, specificity, and cost-effectiveness. Lateral flow assays are extensively used for rapid, point-of-care testing, while ELISA remains a gold standard for laboratory-based diagnostics. Growing incidence of allergies in companion animals is boosting demand for allergen-specific immunodiagnostic tests. Immunoassay analyzers and radioimmunoassays continue to support advanced biomarker and hormone detection, particularly in reference laboratory settings.
• Clinical Biochemistry: This segment is driven by routine health screening and chronic disease monitoring in both companion and livestock animals. Clinical chemistry analysis and glucose monitoring are widely used for metabolic and endocrine assessments, supported by increasing availability of reagent cartridges and automated analyzers. Blood gas and electrolyte analysis is gaining importance in emergency and critical care diagnostics, strengthening adoption across veterinary hospitals and clinics.
• Molecular Diagnostics: Molecular diagnostics is witnessing rapid growth due to its ability to deliver highly accurate and early disease detection. PCR-based tests are increasingly used for identifying infectious pathogens and genetic disorders, particularly in laboratory environments. Expanding applications in proteomics and genomics are further enhancing the relevance of this technology in advanced veterinary diagnostics.z
• Hematology: Hematology diagnostics are essential for routine blood analysis and disease monitoring. The segment benefits from widespread adoption of hematology analyzers and cartridges that support complete blood counts and rapid clinical assessments, particularly in companion animal care.
• Urinalysis: Urinalysis remains a standard diagnostic tool for detecting renal, metabolic, and urinary tract disorders. Growing prevalence of chronic kidney disease (CKD) in cats and dogs is driving increased use of urine analyzers, test strips, and reagent panels across veterinary practices.
• Other Technologies: This segment includes emerging and specialized diagnostic approaches that complement conventional testing methods. Ongoing innovation and integration of novel diagnostic platforms are expected to support incremental market growth.

By Animal Type

• Companion Animals: Companion animals represent the largest market share, supported by rising pet ownership, increased awareness of animal health, and higher spending on preventive and advanced diagnostics. Dogs and cats account for the majority of diagnostic testing, while growing focus on equine health is expanding demand for diagnostics in horses.
• Livestock: The livestock segment is driven by the need to improve herd health, productivity, and disease control. Diagnostics for cattle, pigs, and poultry are increasingly used to monitor infectious diseases, support food safety, and enhance livestock management, particularly in large-scale farming operations.

By Application

• Infectious Diseases: Infectious disease diagnostics dominate the application landscape, driven by the high prevalence of bacterial, viral, and parasitic infections across animal populations. Rapid and accurate detection is critical for effective treatment, disease control, and outbreak prevention, supporting strong demand for diagnostic solutions.
• Endocrinology: Rising incidence of metabolic and hormonal disorders, including diabetes, is increasing adoption of endocrinology diagnostics, particularly in companion animals.
• Cardiology: Growing cases of cardiovascular conditions in pets, especially dogs, are driving demand for cardiac diagnostic tests and monitoring tools.
• Oncology: Increasing awareness and diagnosis of animal cancers, particularly canine oncology, is supporting growth in specialized diagnostic testing.
• Other Applications: Additional applications include diagnostics for gastrointestinal, neurological, and immune-related disorders, contributing to the expanding scope of veterinary diagnostics.

By End User

• Veterinary Reference Laboratories: Reference laboratories hold a substantial market share due to high testing volumes, advanced infrastructure, and availability of skilled personnel. These facilities play a key role in complex and high-throughput diagnostic testing.
• Veterinary Hospitals & Clinics: Hospitals and clinics are major end users, driven by growing pet ownership, increasing demand for in-house testing, and the need for rapid diagnostic results to support clinical decision-making.
• Point-of-Care / In-House Testing: This segment is experiencing strong growth as veterinarians increasingly adopt rapid, cost-effective diagnostic solutions that enable immediate results and improved patient management.
• Veterinary Research Institutes & Universities: Research and academic institutions contribute to market growth through diagnostic research, technology validation, and disease surveillance programs, supporting innovation in veterinary diagnostics.

Top Key Players for Veterinary Diagnostics Market

• Virbac
• IDEXX Laboratories, Inc.
• Antech Diagnostics, Inc. (Mars Inc.)
• Agrolabo S.p.A.
• Embark Veterinary, Inc.
• Esaote SPA
• Thermo Fisher Scientific, Inc.
• Innovative Diagnostics SAS
• FUJIFILM Corporation
• Zoetis

To Know an Additional List of Key Players, Request Here to Download a Free Report PDF Brochure: https://www.vantagemarketresearch.com/veterinary-diagnostics-market-1529/request-sample

Segments Covered in the Report

By Product

• Consumables
• Instruments

By Technology

• Immunodiagnostics
  • Lateral flow assays
  • ELISA
  • Allergen-specific immunodiagnostic tests
  • Immunoassay analyzers
  • Radioimmunoassays
  • Other immunodiagnostic products
• Clinical Biochemistry
  • Clinical chemistry analysis
    • Clinical chemistry reagent clips & cartridges
    • Clinical chemistry analyzers
  • Glucose monitoring
    • Blood glucose strips
    • Glucose monitors
    • Urine glucose strips
  • Blood gas & electrolyte analysis
    • Blood gas & electrolyte reagent clips & cartridges
    • Blood gas & electrolyte analyzers
• Molecular Diagnostics
• Hematology
• Urinalysis
• Other Technologies

By Animal Type

• Companion Animals
  • Dogs
  • Cats
  • Horses
  • Other Companion Animals
• Livestock
  • Cattle
  • Pigs
  • Poultry
  • Other Livestock Animals

By Application

• Infectious Diseases
  • Bacterial infections
  • Viral infections
  • Parasitic infections
  • Other infections
• Endocrinology
• Cardiology
• Oncology
• Other Applications

By End User

• Veterinary Reference Laboratories
• Veterinary Hospitals & Clinics
• Point-of-Care / In-House Testing
• Veterinary Research Institutes & Universities

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Spain
• Nordic Countries
• Benelux Union
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• South-East Asia
• Rest of Asia Pacific
• Latin America
• Brazil
• Argentina
• Rest of Latin America
• Middle East & Africa (MEA)
• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of MEA

Buy this Premium Research Report with Discount | Immediate Delivery @ https://www.vantagemarketresearch.com/veterinary-diagnostics-market-1529/checkout

Key Questions Answered in The Report:

• Which regions are expected to witness the fastest growth in veterinary diagnostics adoption through 2035, and what factors are driving demand across companion animal clinics, livestock operations, reference laboratories, and government animal health agencies?
• How are evolving veterinary regulations, animal health policies, food safety standards, and biosecurity frameworks influencing the development, validation, and commercialization of veterinary diagnostic technologies?
• Who are the leading global and regional players in the veterinary diagnostics ecosystem, and how do their technology portfolios, test menus, and go-to-market strategies differ across companion animal, livestock, and poultry applications?
• Which emerging startups and animal health innovators are disrupting the veterinary diagnostics market through molecular diagnostics, rapid point-of-care testing, AI-enabled interpretation, and portable diagnostic platforms?
• What key technology trends PCR and molecular diagnostics, rapid immunoassays, point-of-care platforms, digital imaging, and AI-assisted diagnostics will most significantly shape the veterinary diagnostics market by 2035?
• How are veterinarians, livestock producers, integrated animal health networks, and public health authorities influencing demand for accurate, scalable, and cost-effective veterinary diagnostic solutions?
• Which business and monetization models are gaining traction in the veterinary diagnostics market, including instrument–reagent models, subscription-based diagnostic services, reference laboratory partnerships, and government-supported disease surveillance programs?  

Gain instant access to our exclusive, data-driven dashboard designed for healthcare industry decision-makers, strategists, and market leaders. The platform delivers in-depth statistical insights, segment-wise breakdowns, regional market performance, competitive landscape mapping, company profiles, annual updates, and more. From market sizing to trend analysis and competitive intelligence, this powerful tool serves as a comprehensive solution for informed business decisions.

Browse the Full "Veterinary Diagnostics Market Trends, Growth & Innovations (2025–2035) by Product Type (Instruments, Consumables), by Animal Type (Companion Animals, Livestock), by Technology (Immunodiagnostics, Clinical Biochemistry, Molecular Diagnostics, Hematology), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa" Report at https://www.vantagemarketresearch.com/industry-report/veterinary-diagnostics-market-1529

Browse More Related Reports:     

• Single Cell Analysis Market is valued at USD 4.90 Billion in 2024 and is projected to reach a value of USD 21.97 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 16.55% between 2025 and 2035 https://www.vantagemarketresearch.com/industry-report/single-cell-analysis-market-1295
• NGS informatics Market is valued at USD 7.21 Billion in 2024 and is projected to reach a value of USD 25.43 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 12.15% between 2025 and 2035 https://www.vantagemarketresearch.com/industry-report/ngs-informatics-market-1439
• Medical Exoskeleton Market is valued at USD 1.09 Billion in 2024 and is projected to reach a value of USD 8.925 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 21.15% between 2025 and 2035 https://www.vantagemarketresearch.com/industry-report/medical-exoskeleton-market-1184
• Pharmaceutical Membrane Filtration Market is valued at USD 11.2 Billion in 2024 and is projected to reach a value of USD 24.53 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 7.40% between 2025 and 2035 https://www.vantagemarketresearch.com/industry-report/pharmaceutical-membrane-filtration-market-1161
• Behavioral Mental Health Software Market is valued at USD 4.1 Billion in 2024 and is projected to reach a value of USD 12.58 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 10.75% between 2025 and 2035 https://www.vantagemarketresearch.com/industry-report/behavioral-mental-health-software-market-1330
• Autologous Cell Therapy Product Market is valued at USD 5.41 Billion in 2024 and is projected to reach a value of USD 50.35 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 22.55% between 2025 and 2035 https://www.vantagemarketresearch.com/industry-report/autologous-cell-therapy-product-market-1298
• Vein Illuminator Market is valued at USD 0.084 Billion in 2024 and is projected to reach a value of USD 1.055 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 25.95% between 2025 and 2035 https://www.vantagemarketresearch.com/industry-report/vein-illuminator-market-1262
• Prostate Specific Antigen (PSA) Testing Market is valued at USD 4.1 Billion in 2024 and is projected to reach a value of USD 13.36 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 11.35% between 2025 and 2035 https://www.vantagemarketresearch.com/industry-report/prostate-specific-antigen-psa-testing-market-1321
• Atrial Fibrillation Market is valued at USD 2.87 Billion in 2024 and is projected to reach a value of USD 10.47 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 12.55% between 2025 and 2035 https://www.vantagemarketresearch.com/industry-report/atrial-fibrillation-market-2044
• Sodium Monofluorophosphate Market is valued at USD 417 Million in 2024 and is projected to reach a value of USD 679 Million by 2035 at a CAGR (Compound Annual Growth Rate) of 4.55% between 2025 and 2035 https://www.vantagemarketresearch.com/industry-report/sodium-monofluorophosphate-market-1902

About Us

Vantage Market Research is a trusted partner to Fortune 500 companies and leading biopharma firms, delivering high-quality market research reports and actionable intelligence across healthcare, biotechnology, and advanced cell therapies. Our globally recognized insights empower stakeholders to make informed decisions, anticipate trends, and capitalize on emerging opportunities.

Follow Us on: LinkedIn | Twitter | Facebook | YouTube

Contact us

Priya M   
Head of Growth & Strategic Partnerships
224 W 35th St Ste 500, New York, NY 10001,
United States Tel: +1 (212) 951-1369
Visit Our Website: https://www.vantagemarketresearch.com   
Email: sales@vantagemarketresearch.com | priya.m@vantagemarketresearch.com   

Website:

• Vantage Market Research
• MarketReports.us
• Market Business Insights
• vmr.biz
• v-mr.biz

Logo:  https://mma.prnewswire.com/media/2758208/Vantage_Logo.jpg